Switzerland: First close and first investment of FORTY51 Ventures I

Switzerland-based FORTY51 Ventures has announced the first close of FORTY51 Ventures I at US$43m.  FORTY51 has a core strategy focused on company formation and early-stage investments in biotech mainly in Switzerland, France and Germany. The fund will lead or co-lead early rounds (Seed and Series A) of its growing portfolio which will include both academic and pharma spin-outs. Its…